טוען...
New drug developments in metastatic gastric cancer
Metastatic gastric cancer is associated with a poor prognosis and novel treatment options are desperately needed. The development of targeted therapies heralded a new era for the management of metastatic gastric cancer, however results from clinical trials of numerous targeted agents have been mixed...
שמור ב:
| הוצא לאור ב: | Therap Adv Gastroenterol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6236851/ https://ncbi.nlm.nih.gov/pubmed/30455742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284818808072 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|